Articles de recherche

Découvrez nos prochaines rencontres scientifiques et activités éducatives axées sur la promotion de la collaboration, le partage de nouvelles données probantes et le renforcement des meilleures pratiques dans le traitement des patients atteints de troubles cardiovasculaires liés au cancer.

Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of Doxorubicin cardiotoxicity.

Auteurs :

Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, Zhang H, Pommier Y.

Publication :

Clinical Cancer Research

Date :

2014 Sep 15

Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.

Auteurs :

Hassan MH, El-Beshbishy HA, Aly H, Attia SM, Bahashwan SA, Ghobara MM.

Publication :

Cancer Chemotherapy and Pharmacology

Date :

2014 Sep

IMRT sparing of normal tissues in locoregional treatment of breast cancer.

Auteurs :

Caudrelier JM, Meng J, Esche B, Grimard L, Ruddy T, Amjadi K.

Publication :

Radiation Oncology

Date :

2014 Jul 22

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study.

Auteurs :

Lorusso V, Giotta F, Bordonaro R, Maiello E, Del Prete S, Gebbia V, Filippelli G, Pisconti S, Cinieri S, Romito S, Riccardi F, Forcignanò R, Ciccarese M, Petrucelli L, Saracino V, Lupo LI, Gambino A, Leo S.

Publication :

International Journal of Oncology

Date :

2014 Nov

Cytoprotective potential of anti-ischemic drugs against chemotherapy-induced cardiotoxicity in H9c2 myoblast cell line.

Auteurs :

Feridooni T, Mac Donald C, Shao D, Yeung P, Agu RU.

Publication :

Acta Pharmaceutica

Date :

2013 Dec

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report fromthe American Society of Echocardiography and the European Association of Cardiovascular Imaging

Auteurs :

Juan Carlos Plana, Maurizio Galderisi, Ana Barac, Michael S. Ewer, Bonnie Ky, Marielle Scherrer-Crosbie, Javier Ganame, Igal A. Sebag, Deborah A. Agler, Luigi P. Badano, Jose Banchs, Daniela Cardinale, Joseph Carver, Manuel Cerqueira, Jeanne M. DeCara, Thor Edvardsen, Scott D. Flamm, Thomas Force, Brian P. Griffin, Guy Jerusalem, Jennifer E. Liu, Andreia Magalha˜es, Thomas Marwick, Liza Y. Sanchez, Rosa Sicari, Hector R. Villarraga, and Patrizio Lancellotti

Publication :

European Heart Journal - Cardiovascular Imaging

Date :

September 2014

Cardiovascular Effects of Phaleria macrocarpa Extracts Combined with Mainstay FAC Regimen for Breast Cancer.

Auteurs :

Anggadiredja K, Tjandrawinata RR.

Publication :

Cardiovascular Toxicology

Date :

2014 Aug 27

Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease.

Auteurs :

Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J.

Publication :

European Heart Journal

Date :

2014 Mar

Electrocardiography changes during adjuvant breast cancer therapy: incidence and risk factors.

Auteurs :

Elme A, Saarto T, Tötterman KJ, Utrianen M, Kautiainen H, Järvenpää S, Tenhuen M, Blomqvist C.

Publication :

Anticancer Research

Date :

2013 Nov

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial.

Auteurs :

Rini BI, Quinn DI, Baum M, Wood LS, Tarazi J, Rosbrook B, Arruda LS, Cisar L, Roberts WG, Kim S, Motzer RJ.

Publication :

Targeted Oncology

Date :

March 5, 2014